Effect of supplementation in treatment of patients with diabetic hemodialysis
Phase 3
- Conditions
- Hemodialysis.Chronic kidney disease
- Registration Number
- IRCT201611155623N92
- Lead Sponsor
- Vice chancellor for research, Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with diabetic hemodialysis
Aged 18 to 80 years
Exclusion Criteria
Taking vitamin D,antioxidant and/or anti-inflammatory supplements
Taking immunosuppressive medications within 3 months prior to the enrollment in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Questionnaire.;Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.
- Secondary Outcome Measures
Name Time Method